Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Garrison Park, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Garrison Park patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Garrison Park: Texas Weight Loss - South Austin, Blue Tree Health - Medical Weight Loss and TLC Medical Weight Loss. Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
For Garrison Park residents, the essentials on ozempic. Asking for 'Ozempic' often means asking for semaglutide: the physician then chooses the form (diabetes brand, weight brand, or compounded) that fits best.
The goal of the evaluation is not to screen for the sake of screening, but to make sure the expected benefit outweighs the risks. Pregnancy and breastfeeding are among the situations where these treatments are not indicated.
Ozempic belongs to the 'GLP-1 agonist (brand of semaglutide, diabetes indication)' class and is given as a weekly subcutaneous injection. Typical dosing: 0.25 mg to start, then 0.5 / 1.0 / 2.0 mg by glycemic response and tolerance. Around Garrison Park in Travis County, 3 weight-management practice(s) are listed locally. For a Garrison Park resident, Ozempic is now largely managed remotely, home delivery included.
Same molecule (semaglutide). Ozempic is dosed/approved for diabetes, Wegovy for chronic weight loss.
That is an off-label use. Many physicians prescribe it, but the FDA indication for weight loss is Wegovy (same active ingredient, semaglutide, at a higher dose).
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.